Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Sun, 03/10/2024 - 16:56 Siyuan Wang siyuan.wang@yale.edu 2037854511 Session 6: Cancer Biology A genome-wide single-cell 3D genome atlas of lung cancer progression Miao Liu Yale University Department of Genetics
  • First Name: Shengyan
    Last Name: Jin
    Affiliation: Yale University Department of Genetics
  • First Name: Sherry
    Last Name: Agabiti
    Affiliation: Yale University Department of Genetics
  • First Name: Tyler
    Last Name: Jensen
    Affiliation: Yale University Department of Genetics
  • First Name: Tianqi
    Last Name: Yang
    Affiliation: Yale University Department of Genetics
  • First Name: Jonathan
    Last Name: Radda
    Affiliation: Yale University Department of Genetics
  • First Name: Christian
    Last Name: Ruiz
    Affiliation: Yale University Department of Genetics
  • First Name: Gabriel
    Last Name: Baldissera
    Affiliation: Yale University Department of Genetics
  • First Name: Mandar
    Last Name: Muzumdar
    Affiliation: Yale University Department of Genetics, Department of Internal Medicine, Yale Cancer Biology Institute, Yale Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 23:49 Ling Cai ling.cai.30@gmail.com 2146975362 Session 6: Cancer Biology A Lung Cancer Mouse Model Database Ling Cai Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center Abstract_Submission.pdf
Cai_UTSW_6.docx15.39 KB
No Approved to be a Poster Presenter
Mon, 03/11/2024 - 03:50 James Kim James.Kim@UTSouthwestern.edu 214-648-4180 Session 4: Small Cell Lung Cancer A Model of Human Small Cell Lung Cancer Metastasis Utilizing Orthotopic Transplantation of Patient-Derived Xenografts Shreoshi Pal Choudhuri University of Texas Southwestern
  • First Name: Kyle
    Last Name: May
    Affiliation: University of Texas Southwestern
  • First Name: Thomas
    Last Name: Salisbury
    Affiliation: University of Texas Southwestern
  • First Name: Chamey
    Last Name: Suchors
    Affiliation: University of Texas Southwestern
  • First Name: Braeden
    Last Name: Freitas
    Affiliation: University of Texas Southwestern
  • First Name: Seth
    Last Name: Hamilton
    Affiliation: University of Texas Southwestern
  • First Name: Victor
    Last Name: Chien
    Affiliation: University of Texas Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: University of Texas Southwestern
  • First Name: James
    Last Name: Kim
    Affiliation: University of Texas Southwestern
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:59 Triparna Sen triparna.sen@mssm.edu 9179723836 Session 3: Immuno-oncology ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes anti-tumor immunity in SCLC. Triparna Sen Icahn School of Medicine at Mount Sinai Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:59 Mustafa Al-Dulaimi mustafa_al-dulaimi@dfci.harvard.edu 12087180181 Session 6: Cancer Biology CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) Mustafa Al-Dulaimi DFCI
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Matthew
    Last Name: Booker
    Affiliation: DFCI
  • First Name: Nathanael
    Last Name: Gray
    Affiliation: Stanford Cancer Institute
  • First Name: Michael
    Last Name: Tolsturokov
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Janne
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 13:42 Sampada Chande sampada.chande@yale.edu 6097722949 Session 6: Cancer Biology Characterization of tumor-neuron communication in lung adenocarcinoma brain metastasis Sampada Chande Department of Pathology, Yale University School of Medicine
  • First Name: Atsushi
    Last Name: Yamasaki
    Affiliation: Daiichi Sankyo Co., Ltd., Tokyo, Japan
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale University School of Medicine
 Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 17:40 Jia Luo jia_luo@dfci.harvard.edu 6176323000 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies Alessandro Di Federico DFCI
  • First Name: Lingzhi
    Last Name: Hong
    Affiliation: MDACC
  • First Name: Arielle
    Last Name: Elkrief
    Affiliation: MSKCC
  • First Name: Rohit
    Last Name: Thummalapalli
    Affiliation: MSKCC
  • First Name: Biagio
    Last Name: Ricciuti
    Affiliation: DFCI
  • First Name: Joao
    Last Name: Alessi
    Affiliation: DFCI
  • First Name: Pooja
    Last Name: Gogia
    Affiliation: MSKCC
  • First Name: Federica
    Last Name: Pecci
    Affiliation: DFCI
  • First Name: Malini
    Last Name: Gandhi
    Affiliation: DFCI
  • First Name: Marc
    Last Name: Ladanyi
    Affiliation: MSKCC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
  • First Name: Mizuki
    Last Name: Nishino
    Affiliation: DFCI
  • First Name: Lynette
    Last Name: Sholl
    Affiliation: BWH
  • First Name: Mark
    Last Name: Awad
    Affiliation: DFCI
  • First Name: Kathryn
    Last Name: Arbour
    Affiliation: MSKCC
  • First Name: Adam
    Last Name: Schoenfeld
    Affiliation: MSKCC
  • First Name: Natalie
    Last Name: Vokes
    Affiliation: MDACC
  • First Name: Jia
    Last Name: Luo
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 12:47 Jessie Hao jessie.hao@emory.edu 4705423594 Session 6: Cancer Biology Co-occurring genomic alterations-guided in silico discovery of therapeutic vulnerability in lung adenocarcinoma Jessie Hao Department of Pharmacology and Chemical Biology, Emory University School of Medicine
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:17 Kersten Pierre kpier26@emory.edu 8324019591 Session 2: Health Disparities in Lung Cancer, Session 3: Immuno-oncology Communication Issues in Patient/Provider Discussions of Immunotherapy Kersten Pierre Winship Cancer Institute at Emory University
  • First Name: Ayannah
    Last Name: Lang
    Affiliation: Winship Cancer Institute at Emory University
  • First Name: Rebecca
    Last Name: Pentz, PhD
    Affiliation: Winship Cancer Institute at Emory University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Wed, 03/13/2024 - 16:10 Luisa Solis Soto lmsolis@mdanderson.org 8327941469 Session 3: Immuno-oncology Comparison of Spatial transcriptomic platforms in lung adenocarcinoma tissue samples Nejla Ozirmak UT-MDACC
  • First Name: Max
    Last Name: Molina
    Affiliation: UT-MDACC
  • First Name: Sharia
    Last Name: Hernandez
    Affiliation: UT-MDACC
  • First Name: Alejandra
    Last Name: Serrano
    Affiliation: UT-MDACC
  • First Name: Wei
    Last Name: Lu
    Affiliation: UT-MDACC
  • First Name: Sean
    Last Name: Barnes
    Affiliation: UT-MDACC
  • First Name: Beatriz
    Last Name: Sanchez-Espiridion
    Affiliation: UT-MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: UT-MDACC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: UT-MDACC
  • First Name: Boris
    Last Name: Sepesi
    Affiliation: UT-MDACC
  • First Name: Tina
    Last Name: Cascone
    Affiliation: UT-MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: UT-MDACC
  • First Name: Khaja
    Last Name: Khan
    Affiliation: UT-MDACC
  • First Name: Ignacio
    Last Name: Wistuba
    Affiliation: UT-MDACC
  • First Name: Cara
    Last Name: Haymaker
    Affiliation: UT-MDACC
  • First Name: Ken
    Last Name: Chen
    Affiliation: UT-MDACC
  • First Name: Luisa
    Last Name: Solis Soto
    Affiliation: UT-MDACC
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 00:05 Kevin Levine klevine2@fredhutch.org Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Continued EGFR Dependency in a Patient with Lung Cancer Harboring an EGFR Kinase Domain Duplication Kevin Levine Fred Hutch Cancer Center
  • First Name: Alice
    Last Name: Berger
    Affiliation: Fred Hutch Cancer Center
  • First Name: Colin
    Last Name: Pritchard
    Affiliation: University of Washington
  • First Name: Christina
    Last Name: Baik
    Affiliation: Fred Hutch Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/04/2024 - 17:35 Matthew Oser matthew_oser@dfci.harvard.edu 9174883166 Session 4: Small Cell Lung Cancer Cyclin A/B RxL Macrocyclic Peptide Inhibitors as a Therapeutic Strategy for Small Cell Lung Cancers with High E2F Activity Shilpa Singh Dana-Farber Cancer Institute
  • First Name: Catherine
    Last Name: Gleason
    Affiliation: Circle Pharma
  • First Name: Min
    Last Name: Fang
    Affiliation: UT Southwestern
  • First Name: Vishal
    Last Name: Khivansara
    Affiliation: UT Southwestern
  • First Name: Shanhai
    Last Name: Xie
    Affiliation: UT Southwestern
  • First Name: Yavuz
    Last Name: Durmaz
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Aniruddha
    Last Name: Sarkar
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Yasmin
    Last Name: Laimon
    Affiliation: BWH
  • First Name: Varunika
    Last Name: Savla
    Affiliation: BWH
  • First Name: James
    Last Name: Aggen
    Affiliation: Circle Pharma
  • First Name: Li-Fen
    Last Name: Liu
    Affiliation: Circle Pharma
  • First Name: Bernard
    Last Name: Levin
    Affiliation: Circle Pharma
  • First Name: Evelyn
    Last Name: Wang
    Affiliation: Circle Pharma
  • First Name: Sabina
    Last Name: Signoretti
    Affiliation: BWH
  • First Name: Alexander
    Last Name: Spektor
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Constantine
    Last Name: Kreatsoulas
    Affiliation: Circle Pharma
  • First Name: Rajinder
    Last Name: Singh
    Affiliation: Circle Pharma
  • First Name: David
    Last Name: Earp
    Affiliation: Circle Pharma
  • First Name: Pablo
    Last Name: Garcia
    Affiliation: Circle Pharma
  • First Name: Deepak
    Last Name: Nijhawan
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 14:39 Tikvah Hayes TKHayes@mednet.ucla.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Deep Mutational Scanning of EGFR Reveals Potential Domain-Specific TKI Sensitivities in Lung Cancer Tikvah Hayes UCLA Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 03:47 Catherine Meador cbmeador@mgh.harvard.edu 9192603477 Session 4: Small Cell Lung Cancer Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling Catherine Meador Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Talal
    Last Name: El Zarif
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Xintao
    Last Name: Qiu
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Ji-Heui
    Last Name: Seo
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Davidsohn
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Hunter
    Last Name: Savignano
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Gitanjali
    Last Name: Lakshminaranan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Heather
    Last Name: McClure
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: John
    Last Name: Canniff
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Brad
    Last Name: Fortunato
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Rong
    Last Name: Li
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Mandeep
    Last Name: Banwait
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Karl
    Last Name: Semaan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Marc
    Last Name: Eid
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Henry
    Last Name: Long
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Yin
    Last Name: Hung
    Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Navin
    Last Name: Mahadevan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: David
    Last Name: Barbie
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Oser
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Zofia
    Last Name: Piotrowska
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Toni
    Last Name: Choueiri
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Sylvan
    Last Name: Baca
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Aaron
    Last Name: Hata
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Matthew
    Last Name: Freedman
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Jacob
    Last Name: Berchuck
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 17:58 Hye Mi Kim hyk61@pitt.edu 4122300387 Session 3: Immuno-oncology Development and Induction of Tertiary Lymphoid Structures in Lung Cancer for Improved Immunotherapeutics Hye Mi Kim University of Pittsburgh School of Medicine
  • First Name: Medard
    Last Name: Kaiza
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Ian
    Last Name: MacFawn
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Noor
    Last Name: Nader
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Elaine
    Last Name: Byrnes
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Alexandra
    Last Name: McDonough
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Caleb
    Last Name: Lampenfeld
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Sheryl
    Last Name: Kunning
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Asia
    Last Name: Williams
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Ashwin
    Last Name: Somasundaram
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Kelsey
    Last Name: Ertwine
    Affiliation: University of Pittsburgh School of Medicine
  • First Name: Stephen
    Last Name: Thorne
    Affiliation: KaliVir Immunotherapeutics
  • First Name: Laura
    Last Name: Stabile
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Tullia
    Last Name: Bruno
    Affiliation: UPMC Hillman Cancer Center
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:40 Kelly Becht kelly.becht@yale.edu (603) 401-2345 Session 2: Health Disparities in Lung Cancer Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer Kelly Becht Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Meghan
    Last Name: Lindsay
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: Pamela
    Last Name: Soulos
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: James
    Last Name: Hansen
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Charu
    Last Name: Singh
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Yi
    Last Name: An
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sanjay
    Last Name: Aneja
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Department of Medicine, Section of Medical Oncology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Henry
    Last Name: Park
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Tue, 02/20/2024 - 09:01 May-Lucie Meyer may-lucie.meyer@mssm.edu Session 4: Small Cell Lung Cancer, Session 6: Cancer Biology DLL3 expression in early-stage SCLC: comparative analysis of IHC and mRNA ISH May-Lucie Meyer Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
  • First Name: Hui
    Last Name: Yu
    Affiliation: Medical Oncology, University ofColorado Anschutz Campus, Aurora, USA
  • First Name: Zoltan
    Last Name: Lohinai
    Affiliation: OKTPI-Koranyi National Institute, Budapest, Hungary
  • First Name: Grace
    Last Name: van Hyfte
    Affiliation: epartment of Population HealthScience and Policy, Icahn School of Medicine at Mount Sinai, New York, USA
  • First Name: Fred
    Last Name: Hirsch
    Affiliation: Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter DLL3 expression in SCLC Poster.jpeg